5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.99▼ | 2.00▼ | 2.01▼ | 2.03▼ | 2.00▼ |
MA10 | 2.00▼ | 2.01▼ | 2.04▼ | 2.01▼ | 2.12▼ |
MA20 | 2.02▼ | 2.04▼ | 2.04▼ | 2.00▼ | 3.14▼ |
MA50 | 2.04▼ | 2.07▼ | 2.04▼ | 2.16▼ | N/A |
MA100 | 2.06▼ | 2.02▼ | 2.00▼ | 3.34▼ | N/A |
MA200 | 2.04▼ | 2.01▼ | 2.06▼ | 7.47▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | -0.007▼ | -0.010▼ | 0.032▲ | 0.180▲ |
RSI | 38.417▼ | 40.861▼ | 42.458▼ | 44.657▼ | 32.975▼ |
STOCH | 20.671 | 16.964▼ | 20.088 | 61.840 | 9.355▼ |
WILL %R | -83.333▼ | -90.909▼ | -81.818▼ | -58.209 | -95.798▼ |
CCI | -59.797 | -90.806 | -94.111 | 35.101 | -60.521 |
Wednesday, May 28, 2025 01:05 PM
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell ...
|
Wednesday, May 14, 2025 05:00 PM
The latest price target for Artiva Biotherapeutics (NASDAQ:ARTV) was reported by Needham on May 15, 2025. The analyst firm set a price target for $18.00 expecting ARTV to rise to within 12 months ...
|
Tuesday, May 13, 2025 01:15 PM
Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and cancers ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 2.06 | 2.14 | 1.96 | 1.98 | 175,266 |
12/06/25 | 1.97 | 2.15 | 1.89 | 2.05 | 124,920 |
11/06/25 | 2.14 | 2.14 | 1.96 | 1.96 | 172,729 |
10/06/25 | 2.08 | 2.175 | 2.03 | 2.065 | 135,866 |
09/06/25 | 2.12 | 2.1499 | 2.07 | 2.11 | 57,484 |
06/06/25 | 1.98 | 2.14 | 1.98 | 2.10 | 212,193 |
05/06/25 | 1.97 | 2.00 | 1.915 | 1.96 | 79,961 |
04/06/25 | 1.96 | 1.99 | 1.93 | 1.97 | 72,972 |
03/06/25 | 1.9028 | 1.99 | 1.9028 | 1.95 | 120,653 |
02/06/25 | 1.97 | 1.9936 | 1.84 | 1.94 | 150,316 |
|
|
||||
|
|
||||
|
|